The 36-month beta value for RZLT is also noteworthy at 0.90. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for RZLT is 49.49M, and at present, short sellers hold a 4.36% of that float. The average trading volume of RZLT on March 19, 2025 was 463.57K shares.
RZLT) stock’s latest price update
Rezolute Inc (NASDAQ: RZLT) has experienced a decline in its stock price by -3.71 compared to its previous closing price of 3.50. However, the company has seen a fall of -5.34% in its stock price over the last five trading days. seekingalpha.com reported 2025-02-18 that Rezolute is a microcap biopharma focused on developing therapies for hypoglycemia caused by hyperinsulinism, with promising late-stage trials for RZ358 and RZ402. RZ358 targets Congenital Hyperinsulinism and Tumor Hyperinsulinism, showing significant efficacy in reducing hypoglycemia in phase 2 trials. Financially, RZLT has a market cap of $279mn, $105mn in cash, and a cash runway of 5–7 quarters, with manageable expenses.
RZLT’s Market Performance
Rezolute Inc (RZLT) has experienced a -5.34% fall in stock performance for the past week, with a -26.90% drop in the past month, and a -27.37% drop in the past quarter. The volatility ratio for the week is 6.30%, and the volatility levels for the past 30 days are at 6.60% for RZLT. The simple moving average for the past 20 days is -16.11% for RZLT’s stock, with a -28.76% simple moving average for the past 200 days.
Analysts’ Opinion of RZLT
Many brokerage firms have already submitted their reports for RZLT stocks, with Wedbush repeating the rating for RZLT by listing it as a “Outperform.” The predicted price for RZLT in the upcoming period, according to Wedbush is $12 based on the research report published on November 05, 2024 of the previous year 2024.
Guggenheim, on the other hand, stated in their research note that they expect to see RZLT reach a price target of $11. The rating they have provided for RZLT stocks is “Buy” according to the report published on August 27th, 2024.
BTIG Research gave a rating of “Buy” to RZLT, setting the target price at $13 in the report published on July 17th of the previous year.
RZLT Trading at -26.51% from the 50-Day Moving Average
After a stumble in the market that brought RZLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.52% of loss for the given period.
Volatility was left at 6.60%, however, over the last 30 days, the volatility rate increased by 6.30%, as shares sank -29.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.56% lower at present.
During the last 5 trading sessions, RZLT fell by -5.34%, which changed the moving average for the period of 200-days by -18.40% in comparison to the 20-day moving average, which settled at $4.02. In addition, Rezolute Inc saw -31.22% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RZLT starting from Hogenhuis Wladimir, who purchase 10,000 shares at the price of $4.70 back on Feb 18 ’25. After this action, Hogenhuis Wladimir now owns 77,267 shares of Rezolute Inc, valued at $47,000 using the latest closing price.
Kim Young-Jin, the Director of Rezolute Inc, purchase 1,250,000 shares at $4.00 during a trade that took place back on Jun 25 ’24, which means that Kim Young-Jin is holding 7,192,617 shares at $5,000,000 based on the most recent closing price.
Stock Fundamentals for RZLT
Current profitability levels for the company are sitting at:
- -1264.41 for the present operating margin
- 0.72 for the gross margin
The net margin for Rezolute Inc stands at -1226.45. The total capital return value is set at -0.72. Equity return is now at value -74.36, with -66.43 for asset returns.
Based on Rezolute Inc (RZLT), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -32.84.
Currently, EBITDA for the company is -68.42 million with net debt to EBITDA at 0.1. When we switch over and look at the enterprise to sales, we see a ratio of 3396.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.30.
Conclusion
In summary, Rezolute Inc (RZLT) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
